EUVIMEDEUVIMED entdecken
Open Access

Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases

David S Goldstein iD, Parvez Alam, Patti Sullivan, Courtney Holmes, Janna Gelsomino, Andrew G Hughson, Byron Caughey

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.14333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von David S Goldstein und 6 weiteren Autor:innen. Beteiligte Einrichtung: Autonomic Medicine Section (AMS), Clinical Neurosciences Program (CNP), Division of Intramural Research (DIR), National Institute of Neurological Dis…. Hauptthemen laut MEDLINE: Lewy Body Disease, alpha-Synuclein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebrospinal fluid (CSF) α‐synuclein seeding activity (SSA) via a seed amplification assay might predict central Lewy body diseases (LBD) in at‐risk individuals.

Objective

The aim was to assess CSF SSA in a prospective, longitudinal study.

Methods

Participants self‐reported risk factors were genetics, olfactory dysfunction, dream enactment behavior, orthostatic intolerance, or hypotension; individuals who had ≥3 confirmed risk factors underwent CSF sampling and were followed for up to 7.5 years. Participants who developed a central LBD (LBD+) were compared to those who did not. Quadruplicate SSA areas under the curve (AUC) were averaged.

Results

Of 11 subjects with average AUCs above 500,000 units, 7 (64%) developed a central LBD compared to 1 of 20 (5%), with AUCs below the cutoff value ( P = 0.0011 by log‐rank test). Conversely, 7 of 8 (88%) LBD+ participants had elevated initial AUCs.

Conclusions

Increased CSF SSA predicts central LBDs. Individuals who develop a central LBD have elevated initial SSA AUCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lewy Body Diseasealpha-SynucleinHumansMaleFemaleAgedMiddle AgedLongitudinal StudiesProspective StudiesBiomarkersRisk Factors

Stichwörter der Autor:innen

LewyParkinsonbiomarkercerebrospinal fluidsynuclein

Substanzen

alpha-SynucleinBiomarkers

Autor:innen und Institutionen

  • Autonomic Medicine Section (AMS), Clinical Neurosciences Program (CNP), Division of Intramural Research (DIR), National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethes…
  • TSE/Prion Biochemistry Section, DIR, National Institute of Allergy and Infectious Diseases (NIAID), Hamilton, Montana, USA.

ORCID-Profile: David S Goldstein

Förderung

  • NINDS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Goldstein, D. S., Alam, P., Sullivan, P., Holmes, C., Gelsomino, J., Hughson, A. G., & Caughey, B. (2025). Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14333

Vancouver

Goldstein DS, Alam P, Sullivan P, Holmes C, Gelsomino J, Hughson AG, et al. Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.14333

BibTeX
@article{Goldstein2025,
  author = {Goldstein, David S and Alam, Parvez and Sullivan, Patti and Holmes, Courtney and Gelsomino, Janna and Hughson, Andrew G and Caughey, Byron},
  title = {Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.14333}
}
Kostenlos starten →